About Us
Premature ejaculation can have a significant impact on relationships, causing distress and frustration. This condition affects men across various age groups, yet it often goes unaddressed due to embarrassment or reluctance to discuss it with healthcare professionals.
Research from a comprehensive study involving 12,000 individuals across three countries revealed that only 9% of those seeking treatment experienced improvement. This statistic highlights the need for a new approach, which is precisely what sets Prolong™ apart in the treatment of premature ejaculation.
Unlike traditional methods that may come with side effects, complexity, high costs, or lifelong dependency, Prolong™ offers a revolutionary solution. It eliminates the need for cumbersome apps, extensive paperwork, meticulous record-keeping, or the involvement of a partner, all while ensuring 100% effectiveness.
Prolong™ is an easily accessible non-prescription treatment that guarantees remarkable results. It can be discreetly used without anyone knowing about it. It removes all barriers to accessing and using the product, allowing individuals to undergo training sessions independently and engage in normal sexual intercourse.
Numerous studies, including a notable collaboration between the esteemed Karolinska Medical School and Åbo University in Finland, have consistently demonstrated the high efficacy of Prolong™.
Dr. Zamar, the inventor of Prolong™, specifically designed the treatment to address the various challenges faced by individuals with premature ejaculation (PE), including:
- Overcoming the initial hurdle of seeking help
- Openly discussing the topic of climax control
- Avoiding therapies, medications, or local anesthetics with potential side effects
- Simplifying treatment programs that require the use of apps
- Delivering satisfying and lasting results
By choosing Prolong™, individuals with premature ejaculation can take control of their condition and enjoy fulfilling sexual experiences.
Prolong Climax Control Training Program
Share
